Treatment of "Low Anterior Resection Syndrome" by Percutaneous Nerve Evaluation and Transanal Irrigation
- Conditions
- Rectal Cancer
- Interventions
- Procedure: Percutaneous nerve evaluation
- Registration Number
- NCT01313026
- Lead Sponsor
- University of Aarhus
- Brief Summary
A randomised trial testing the effect of percutaneous nerve evaluation and transanal irrigation on bowel function in patients after low anterior resection for rectal cancer.
- Detailed Description
Patients will undergo anal physiological assessment and will then be randomized to either treatment arm. The first 12 weeks they will be optimized in the conservative treatment of their bowel function before beginning active treatment with TAI or PNE. After 8 and 4 weeks respectively, the treatment will stop and they will have a period of 4 weeks back on optimized conservative treatment before beginning active treatment in the other active arm.
Detailed records of bowel, micturition and sexual function and QoL will be obtained at regular intervals during the entire trial fase.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 14
- Low anterior resection for rectal cancer between May 2001 and May 2011
- Non-radical resection
- metastatic disease
- Chemotherapy
- Radiotherapy
- Previously treated for another cancer
- Dementia or other mental retardation/severe mental disease
- Inability to read and understand the Danish language
- Recurrent disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description PNE first Percutaneous nerve evaluation patients randomised to start with PNE stimulation over 4 weeks. Then the stimulator will be removed and after a wash out period of 4 weeks they will be trained in transanal irrigation TAI first Percutaneous nerve evaluation Patients randomised to start with transanal irrigation treatment in 8 weeks, thereafter a wash out period of 4 weeks before being implanted with a neuro stimulator
- Primary Outcome Measures
Name Time Method changes in LARS score baseline, 12, 16, 20, 24 and 28 weeks A symptom score ranging from 0 to 42 points calculated on the basis of bowel function
- Secondary Outcome Measures
Name Time Method Incontinence baseline, 12, 16, 20, 24 and 28 weeks faecal incontinence measured by wexner score and St. Marks incontinence score
Sexual function baseline, 12, 16, 20, 24 and 28 weeks self-reported sexual function measured by validated questionnaires
Patient Satisfaction baseline, 12, 16, 20, 24 and 28 weeks patient satisfaction measured on a VAS
Bladder function baseline, 12, 16, 20, 24 and 28 weeks self-reported bladder function by validated questionnaires
Trial Locations
- Locations (1)
Colorectal Surgical Department P, Aarhus University Hospital
🇩🇰Aarhus, Denmark